US Stock MarketDetailed Quotes

ZBIO Zenas BioPharma

Watchlist
  • 7.060
  • -0.390-5.23%
Close Mar 10 16:00 ET
  • 7.060
  • 0.0000.00%
Post 16:20 ET
295.04MMarket Cap-2.29P/E (TTM)
Full Hours
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

Comments

    $Zenas BioPharma (ZBIO.US)$
    Zenas BioPharma Announces Key 2024 Accomplishments and 2025 Business Objectives to Support the Global Development and Commercialization of Therapies for Autoimmune Diseases
    Wednesday, 5th February at 7:05 am
    - Advancing Phase 2 and Phase 3 trials of obexelimab, a unique CD-19 x FcγRIIb inhibitor of B cell function-
    -Topline results from Phase 2 Trial in Relapsing Multiple Sclerosis (MoonStone) expected in third quarter 2025-
    -Topline results from pivotal Phase 3 Tr...
Read more